scholarly journals Successful modulation of high-dose cytosine arabinoside metabolism in acute myeloid leukaemia by haematopoietic growth factors: no effect of ribonucleotide reductase inhibitors fludarabine and gemcitabine

2000 ◽  
Vol 109 (2) ◽  
pp. 388-395 ◽  
Author(s):  
Jan Braess ◽  
Christine Wegendt ◽  
Gerlinde Jahns-Streubel ◽  
Wolfgang Kern ◽  
Susan Keye ◽  
...  
Keyword(s):  
Growth Factors ◽  
Acute Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Ribonucleotide Reductase ◽  
Cytosine Arabinoside ◽  
High Dose ◽  
Reductase Inhibitors ◽  
Ribonucleotide Reductase Inhibitors ◽  
Acute Myeloid

scholarly journals Clofarabine and high-dose cytosine arabinoside in the treatment of refractory or relapsed acute myeloid leukaemia

2011 ◽  
Vol 90 (11) ◽  
pp. 1277-1281 ◽  
Author(s):  
Eric Tse ◽  
Anskar Y. H. Leung ◽  
Joycelyn Sim ◽  
Harold K. K. Lee ◽  
Herman S. Y. Liu ◽  
...  
Keyword(s):  
Acute Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Cytosine Arabinoside ◽  
High Dose ◽  
Acute Myeloid

A phase II trial of high-dose imatinib mesylate for relapsed or refractory c-kit positive and Bcr-Abl negative acute myeloid leukaemia: The AFR-15 trial

2009 ◽  
Vol 33 (8) ◽  
pp. 1124-1126 ◽  
Author(s):  
Patrice Chevallier ◽  
Mathilde Hunault-Berger ◽  
Fabrice Larosa ◽  
Charles Dauriac ◽  
Richard Garand ◽  
...  
Keyword(s):  
Acute Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Imatinib Mesylate ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
High Dose ◽  
Acute Myeloid
Sign in / Sign up

Export Citation Format

Share Document